What they were paid
Elicio Therapeutics Director Compensation Table · the one fiscal year held| Fiscal year | Cash fees | Stock awards | Option awards | Other | Total |
|---|---|---|---|---|---|
| FY2024 | $48,125 | $0 | $17,148 | $0 | $65,273 |
Each year as stated in that year's proxy. A dash means the company reported no figure in that column. Source: Elicio Therapeutics, Inc. DEF 14A filed April 9, 2025, accession 0001601485-25-000062, and prior-year filings. Open the filing on EDGAR.
How this board is paid
company policy · FY2024Elicio Therapeutics pays directors a $40,000 cash retainer.
Committees
FY2024 · as the proxy prints themAudit · Compensation · Nominating/Governance
The rest of the Elicio Therapeutics board
FY2024 · as the company reported each| Director | Role | FY2024 total |
|---|---|---|
| Carol Ashe | Independent Director | $79,648 |
| Jay R. Venkatesan, M.D | Director | $57,148 |
| Julian Adams, Ph.D | Chair of the Board | $104,523 |
| Karen J. Wilson | Independent Director | $77,148 |
| Robert Connelly | Director | $0 |
| Robert R. Ruffolo, Jr., Ph.D., FCPP | Director | $62,148 |
| Yekaterina (Katie) Chudnovsky | Director | $60,717 |
The full Elicio Therapeutics compensation record
free company briefThis page is one director within Elicio Therapeutics's record. The company brief lists every named executive and director, each linking to their own page.
Velarion Pro: every company page, peer tools and exports, one seat